A detailed history of Lvw Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Lvw Advisors, LLC holds 7,351 shares of AMGN stock, worth $2.37 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
7,351
Previous 7,492 1.88%
Holding current value
$2.37 Million
Previous $2.13 Million 7.79%
% of portfolio
0.34%
Previous 0.37%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

SELL
$262.75 - $319.31 $37,047 - $45,022
-141 Reduced 1.88%
7,351 $2.3 Million
Q1 2024

Apr 17, 2024

SELL
$268.87 - $324.56 $647,438 - $781,540
-2,408 Reduced 24.32%
7,492 $2.13 Million
Q4 2023

Jan 12, 2024

SELL
$255.7 - $288.46 $697,549 - $786,918
-2,728 Reduced 21.6%
9,900 $2.85 Million
Q3 2023

Oct 10, 2023

SELL
$218.65 - $271.46 $970,368 - $1.2 Million
-4,438 Reduced 26.0%
12,628 $3.39 Million
Q2 2023

Jul 14, 2023

SELL
$214.27 - $253.37 $301,692 - $356,744
-1,408 Reduced 7.62%
17,066 $3.79 Million
Q1 2023

May 02, 2023

BUY
$225.79 - $275.2 $118,313 - $144,204
524 Added 2.92%
18,474 $4.47 Million
Q4 2022

Jan 18, 2023

SELL
$229.03 - $291.01 $17,635 - $22,407
-77 Reduced 0.43%
17,950 $0
Q3 2022

Oct 13, 2022

BUY
$224.46 - $253.15 $81,030 - $91,387
361 Added 2.04%
18,027 $4.06 Million
Q2 2022

Jul 22, 2022

SELL
$230.71 - $256.74 $94,591 - $105,263
-410 Reduced 2.27%
17,666 $4.3 Million
Q1 2022

May 02, 2022

BUY
$219.27 - $242.57 $267,947 - $296,420
1,222 Added 7.25%
18,076 $4.37 Million
Q4 2021

Jan 26, 2022

BUY
$198.88 - $227.6 $664,259 - $760,184
3,340 Added 24.72%
16,854 $3.79 Million
Q3 2021

Nov 02, 2021

BUY
$212.27 - $248.7 $202,717 - $237,508
955 Added 7.6%
13,514 $2.87 Million
Q2 2021

Jul 15, 2021

BUY
$233.58 - $259.14 $6,306 - $6,996
27 Added 0.22%
12,559 $3.06 Million
Q1 2021

Apr 19, 2021

SELL
$221.91 - $258.6 $5,769 - $6,723
-26 Reduced 0.21%
12,532 $3.12 Million
Q4 2020

Feb 04, 2021

BUY
$216.38 - $257.67 $20,988 - $24,993
97 Added 0.78%
12,558 $2.89 Million
Q3 2020

Oct 29, 2020

SELL
$234.65 - $260.95 $136,097 - $151,351
-580 Reduced 4.45%
12,461 $3.17 Million
Q2 2020

Aug 11, 2020

BUY
$197.81 - $242.74 $76,354 - $93,697
386 Added 3.05%
13,041 $3.08 Million
Q1 2020

Apr 23, 2020

BUY
$182.24 - $241.7 $277,551 - $368,109
1,523 Added 13.68%
12,655 $2.57 Million
Q4 2019

Feb 10, 2020

SELL
$189.21 - $243.2 $7,946 - $10,214
-42 Reduced 0.38%
11,132 $2.68 Million
Q3 2019

Oct 22, 2019

BUY
$174.11 - $208.62 $1.43 Million - $1.72 Million
8,236 Added 280.33%
11,174 $2.16 Million
Q2 2019

Aug 14, 2019

BUY
$166.7 - $195.41 $489,764 - $574,114
2,938 New
2,938 $541,000
Q1 2019

May 03, 2019

SELL
$180.87 - $203.88 $202,393 - $228,141
-1,119 Closed
0 $0
Q4 2018

Feb 05, 2019

BUY
$178.4 - $208.25 $10,704 - $12,495
60 Added 5.67%
1,119 $218,000
Q3 2018

Nov 02, 2018

BUY
$185.29 - $208.89 $196,222 - $221,214
1,059 New
1,059 $220,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $173B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Lvw Advisors, LLC Portfolio

Follow Lvw Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lvw Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lvw Advisors, LLC with notifications on news.